Decreased linear growth associated with intestinal bladder augmentation in children with bladder exstrophy

David Alexandre C Gros, Jennifer Lockwood Dodson, Uri A. Lopatin, John Phillip Gearhart, Richard I. Silver, Steven G. Docimo

Research output: Contribution to journalArticle

Abstract

Purpose: We determine if enterocystoplasty results in delayed linear growth using a case controlled study to observe the effects of intestinal bladder augmentation on growth in patients with bladder exstrophy. Materials and Methods: A total of 50 patients who had undergone bladder augmentation for incontinence due to classic bladder exstrophy were selected from our patient database and matched for gender, age and type of exstrophy with 50 patients who had nonaugmented bladder exstrophy. Patients were then contacted and asked to permit the pediatricians to release growth charts. Once consent was obtained the charts were requested from the pediatricians, and evaluable data, defined as at least 1 height before and after augmentation, were obtained for 17 of 50 (34%) augmented and 15 of 50 (30%) nonaugmented cases. Results: Mean age at surgery was 7.7 years. Delayed growth as defined by a postoperative decrease in percentile height occurred in 14 of 17 (82%) augmented cases (mean loss 15.6 percentile points). Delayed growth after age 7.7 years occurred in 5 of 15 (33%) controls but average growth for the entire group was 6.7 percentile points (p = 0.014). Mean followup was 5.7 years (median 4.9) for the augmented group and 7.3 years (median 8.2) for the control group. Conclusions: Intestinal bladder augmentation is associated with a nearly universal decrease in percentile height. Close long-term followup of these patients and analysis of subtle metabolic alterations may provide information to help minimize or prevent growth impediment in the future.

Original languageEnglish (US)
Pages (from-to)917-920
Number of pages4
JournalJournal of Urology
Volume164
Issue number3 II
StatePublished - Sep 2000

Fingerprint

Bladder Exstrophy
Urinary Bladder
Growth
Growth Charts
Databases
Control Groups

Keywords

  • Bladder exstrophy
  • Growth
  • Pediatrics

ASJC Scopus subject areas

  • Urology

Cite this

Decreased linear growth associated with intestinal bladder augmentation in children with bladder exstrophy. / Gros, David Alexandre C; Dodson, Jennifer Lockwood; Lopatin, Uri A.; Gearhart, John Phillip; Silver, Richard I.; Docimo, Steven G.

In: Journal of Urology, Vol. 164, No. 3 II, 09.2000, p. 917-920.

Research output: Contribution to journalArticle

Gros, David Alexandre C ; Dodson, Jennifer Lockwood ; Lopatin, Uri A. ; Gearhart, John Phillip ; Silver, Richard I. ; Docimo, Steven G. / Decreased linear growth associated with intestinal bladder augmentation in children with bladder exstrophy. In: Journal of Urology. 2000 ; Vol. 164, No. 3 II. pp. 917-920.
@article{5cd3a286d17440e095e9269f6c9c010c,
title = "Decreased linear growth associated with intestinal bladder augmentation in children with bladder exstrophy",
abstract = "Purpose: We determine if enterocystoplasty results in delayed linear growth using a case controlled study to observe the effects of intestinal bladder augmentation on growth in patients with bladder exstrophy. Materials and Methods: A total of 50 patients who had undergone bladder augmentation for incontinence due to classic bladder exstrophy were selected from our patient database and matched for gender, age and type of exstrophy with 50 patients who had nonaugmented bladder exstrophy. Patients were then contacted and asked to permit the pediatricians to release growth charts. Once consent was obtained the charts were requested from the pediatricians, and evaluable data, defined as at least 1 height before and after augmentation, were obtained for 17 of 50 (34{\%}) augmented and 15 of 50 (30{\%}) nonaugmented cases. Results: Mean age at surgery was 7.7 years. Delayed growth as defined by a postoperative decrease in percentile height occurred in 14 of 17 (82{\%}) augmented cases (mean loss 15.6 percentile points). Delayed growth after age 7.7 years occurred in 5 of 15 (33{\%}) controls but average growth for the entire group was 6.7 percentile points (p = 0.014). Mean followup was 5.7 years (median 4.9) for the augmented group and 7.3 years (median 8.2) for the control group. Conclusions: Intestinal bladder augmentation is associated with a nearly universal decrease in percentile height. Close long-term followup of these patients and analysis of subtle metabolic alterations may provide information to help minimize or prevent growth impediment in the future.",
keywords = "Bladder exstrophy, Growth, Pediatrics",
author = "Gros, {David Alexandre C} and Dodson, {Jennifer Lockwood} and Lopatin, {Uri A.} and Gearhart, {John Phillip} and Silver, {Richard I.} and Docimo, {Steven G.}",
year = "2000",
month = "9",
language = "English (US)",
volume = "164",
pages = "917--920",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "3 II",

}

TY - JOUR

T1 - Decreased linear growth associated with intestinal bladder augmentation in children with bladder exstrophy

AU - Gros, David Alexandre C

AU - Dodson, Jennifer Lockwood

AU - Lopatin, Uri A.

AU - Gearhart, John Phillip

AU - Silver, Richard I.

AU - Docimo, Steven G.

PY - 2000/9

Y1 - 2000/9

N2 - Purpose: We determine if enterocystoplasty results in delayed linear growth using a case controlled study to observe the effects of intestinal bladder augmentation on growth in patients with bladder exstrophy. Materials and Methods: A total of 50 patients who had undergone bladder augmentation for incontinence due to classic bladder exstrophy were selected from our patient database and matched for gender, age and type of exstrophy with 50 patients who had nonaugmented bladder exstrophy. Patients were then contacted and asked to permit the pediatricians to release growth charts. Once consent was obtained the charts were requested from the pediatricians, and evaluable data, defined as at least 1 height before and after augmentation, were obtained for 17 of 50 (34%) augmented and 15 of 50 (30%) nonaugmented cases. Results: Mean age at surgery was 7.7 years. Delayed growth as defined by a postoperative decrease in percentile height occurred in 14 of 17 (82%) augmented cases (mean loss 15.6 percentile points). Delayed growth after age 7.7 years occurred in 5 of 15 (33%) controls but average growth for the entire group was 6.7 percentile points (p = 0.014). Mean followup was 5.7 years (median 4.9) for the augmented group and 7.3 years (median 8.2) for the control group. Conclusions: Intestinal bladder augmentation is associated with a nearly universal decrease in percentile height. Close long-term followup of these patients and analysis of subtle metabolic alterations may provide information to help minimize or prevent growth impediment in the future.

AB - Purpose: We determine if enterocystoplasty results in delayed linear growth using a case controlled study to observe the effects of intestinal bladder augmentation on growth in patients with bladder exstrophy. Materials and Methods: A total of 50 patients who had undergone bladder augmentation for incontinence due to classic bladder exstrophy were selected from our patient database and matched for gender, age and type of exstrophy with 50 patients who had nonaugmented bladder exstrophy. Patients were then contacted and asked to permit the pediatricians to release growth charts. Once consent was obtained the charts were requested from the pediatricians, and evaluable data, defined as at least 1 height before and after augmentation, were obtained for 17 of 50 (34%) augmented and 15 of 50 (30%) nonaugmented cases. Results: Mean age at surgery was 7.7 years. Delayed growth as defined by a postoperative decrease in percentile height occurred in 14 of 17 (82%) augmented cases (mean loss 15.6 percentile points). Delayed growth after age 7.7 years occurred in 5 of 15 (33%) controls but average growth for the entire group was 6.7 percentile points (p = 0.014). Mean followup was 5.7 years (median 4.9) for the augmented group and 7.3 years (median 8.2) for the control group. Conclusions: Intestinal bladder augmentation is associated with a nearly universal decrease in percentile height. Close long-term followup of these patients and analysis of subtle metabolic alterations may provide information to help minimize or prevent growth impediment in the future.

KW - Bladder exstrophy

KW - Growth

KW - Pediatrics

UR - http://www.scopus.com/inward/record.url?scp=0033883912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033883912&partnerID=8YFLogxK

M3 - Article

C2 - 10958756

AN - SCOPUS:0033883912

VL - 164

SP - 917

EP - 920

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 3 II

ER -